home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Overcoming the Development and Manufacturing Challenges Associated with Nucleic Acid Therapeutics

 
  January 21, 2022  
     
 
xtalks.com, webinar
Wednesday, February 23, 2022 | 2pm EST


Who Should Attend?

  • Drug discovery scientists
  • Drug development and manufacturing professionals

What You Will Learn

Join this webinar to learn about:

  • An overview of nucleic acid therapeutics development and challenging areas
  • Nucleic acid therapeutics drug substance manufacturing
  • Lipid nanoparticle formulation and testing
  • Key materials and supply
 
 
Organized by: xtalks.com
Invited Speakers:

Speaker

http://Hua%20Tu,%20Curia

Hua Tu, Chief Technology Officer, Curia

Hua Tu joined Curia via the LakePharma acquisition in September 2021. As Chief Technology Officer, he is responsible for technology and innovation at Curia.

Hua brings more than 20 years of experience in the biotech industry to Curia. He founded LakePharma, the biologics company, in 2009 and built the business into one of the premium US-based biologics service providers. Before founding LakePharma, he spent 11 years at Amgen working on various drug development programs.

Hua earned a Bachelor of Science in biochemistry and a PhD in molecular cell biology from SUNY Stony Brook. He has authored more than 30 peer-reviewed publications.

 
Deadline for Abstracts: na
 
Registration: https://xtalks.com/webinars/overcoming-the-development-and-manufacturing-challenges-associated-with-nucleic-acid-therapeutics/
E-mail: shunte@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.